E-mail:
zeeshan@xmu.edu.cn
Correspondence Address:
School of Public Health, Xiamen University, Xiamen, Fujian, China
Research Direction:
1. Translational cancer biology with emphasis on targeted therapy and tumor microenvironment–driven drug resistance.
2. Application of advanced cellular and molecular techniques to dissect oncogenic signaling pathways.
Education：
2022.09–2025.08 PhD Veterinary Medicine, Chungbuk National University, Republic of Korea
2017.09–2019.07 Master of Philosophy in Clinical Medicine and Surgery, University of Agriculture, Faisalabad, Pakistan
2011.09–2017.06 Doctor of Veterinary Medicine (DVM), The Islamia University of Bahawalpur, Pakistan
Published papers:
1. Bhutta, Z. A., Kim, C. W. & Choi, K.-C.. Punicalagin Attenuates Benzo[α]pyrene-Induced Metastasis by Reversing Epithelial-Mesenchymal Transition via Mitochondrial ROS Modulation in Triple-Negative Breast Cancer Cells. Toxicological Research. 2025. https://doi.org/10.1007/s43188-026-00338-y
2. Jeon, S.Y.#, Bhutta, Z.A.#, Lee, H. K. & Choi, K.-C.. Inhibitory effect of progesterone on breast cancer progression and migration via the regulation of epithelial-mesenchymal transition. Oncology Research. 2026. https://doi.org/10.32604/or.2026.071328
3. Shoaib, M.#, Bhutta, Z. A.#, Javed, A., Amjad, M. N., Li, W., Choi, K.-C., & Pu, W. Future of PARP inhibitors in cancer treatment: overcoming resistance and enhancing efficacy with combination therapies. Journal of Zhejiang University-SCIENCE B. 2026, 27: 23–43.
4. Bhutta, Z. A., & Choi, K.-C.. Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges. Archives of Pharmacal Research. 2025, 48(1): 43-61.
5. Bhutta, Z. A., & Choi, K. C.. Phytochemicals as Novel Therapeutics for Triple-Negative Breast Cancer: A Comprehensive Review of Current Knowledge. Phytotherapy Research. 2025, 39(1): 364-396.
6. Bhutta, Z. A., Go, R. E., & Choi, K. C.. Effect of punicalagin on the autophagic cell death in triple-negative breast cancer cells. Toxicological Research. 2024, 40(4): 585-598.
7. Bhutta, Z. A., & Choi, K.-C.. Antitumor Effects of Dietary Compounds. Nutrients. 2023, 15(10): 2349.
8. Bhutta, Z. A., Kanwal, A., Ali, M., Kulyar, M. F.-e.-A., Yao, W., Shoaib, M., Ashar, A., Mahfooz, A., Ijaz, M., Ijaz, N., Asif, M., Nawaz, S., Mahfooz, M. R., & Kanwal, T.. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic. Nanotechnology. 2021, 32(48): 482001.
9. Bhutta, Z. A., Kulyar, M. F.-e.-A., Kanwal, A., Mahfooz, A., Ali, M., & Li, K.. One Health: An inclusive framework to curb the COVID-19 pandemic. EXCLI Journal. 2021, 20: 724-726.
10. Bhutta, Z. A., Ashar, A., Mahfooz, A., Khan, J. A., Saleem, M. I., Rashid, A., Aqib, A. I., Kulyar, M. F.-e.-A., Sarwar, I., Shoaib, M., Nawaz, S., & Yao, W.. Enhanced wound healing activity of nano ZnO and nano Curcuma longa in third-degree burn. Applied Nanoscience, 2021, 11(4): 1267-1278.
